Neurostimulator Is First Device Marketed To Reduce Opioid Withdrawal Symptoms

FDA used its de novo pathway to clear Innovative Health Solution's NSS-2 Bridge – the first device for use in helping to reduce the symptoms of opioid withdrawal – as a class II device.